Evidence map›Paper›PMID 24391998›Full record

ArticlePloS one2013

TAILOR: transgene activation and inactivation using lox and rox in zebrafish.

Joon Tae Park, Steven D Leach

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Fate-Mapping Macrophages: From Ontogeny to Functions.Methods in molecular biology (Clifton, N.J.) · 2024
    Review
  3. Review
  4. Zebrafish Models of Paediatric Brain Tumours.International journal of molecular sciences · 2022
    Review
  5. Cre/eLife · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. A knock-in allele of En1 expressing dre recombinase.Genesis (New York, N.Y. : 2000) · 2016
    Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Joon Tae ParkDepartment of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America.
Steven D LeachDepartment of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America ; McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America.
Johns Hopkins University · US

Funding

SURGICAL STUDIES OF PANCREATIC STEM CELLSR01DK056211 · NIDDK · VANDERBILT UNIVERSITY · PI LEACH, STEVEN D · 1999 to 2014
$4.9M
Transgenic tools for Gal4 regulated gene expression in zebrafishR01HD058530 · NICHD · CARNEGIE INSTITUTION OF WASHINGTON, D.C. · PI HALPERN, MARNIE E, LEACH, STEVEN D · 2008 to 2012
$1.6M
NICHD NIH HHS HD058530NICHD NIH HHS R01 HD058530NIDDK NIH HHS DK56211NIDDK NIH HHS R01 DK056211
6 · The paper itself

Abstract

The ability to achieve precisely tailored activation and inactivation of gene expression represents a critical utility for vertebrate model organisms. In this regard, Cre and other site-specific DNA recombinases have come to play a central role in achieving temporally regulated and cell type-specific genetic manipulation. In zebrafish, both Cre and Flp recombinases have been applied for inducible activation, inactivation and inversion of inserted genomic elements. Here we describe the addition of Dre, a heterospecific Cre-related site-specific recombinase, to the zebrafish genomic toolbox. Combining Dre-based recombination in zebrafish with established Cre/lox technology, we have established an effective strategy for transgene activation and inactivation using lox and rox (TAILOR). Using stable transgenic lines expressing tamoxifen-inducible CreER(T2) and RU486-inducible DrePR fusions, we demonstrate that Cre and Dre retain non-overlapping specificities for their respective lox and rox target sites in larval zebrafish, and that their combinatorial and sequential activation can achieve precisely timed transgene activation and inactivation. In addition to TAILOR, the successful application of Dre/rox technology in zebrafish will facilitate a variety of additional downstream genetic applications, including sequential lineage labeling, complex genomic rearrangements and the precise temporal and spatial control of gene expression through the intersection of partially overlapping promoter activities.

Indexed as

Gene Transfer TechniquesAnimalsEscherichia coli ProteinsGene Expression RegulationIntegrasesMicroscopy, ConfocalMifepristoneRecombinasesSubstrate SpecificityTransgenesZebrafishCre recombinaseDre recombinase, E coliEscherichia coli ProteinsIntegrasesMifepristoneRecombinases

Identifiers

PMID24391998
PMCPMC3877360
OpenAlexW2037517685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.